ArticleACS materials Au2025
Development of Biocompatible, UV and NIR Excitable Nanoparticles with Multiwavelength Emission and Enhanced Colloidal Stability.
Article in ACS materials Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Surface bioengineering of lanthanide nanoparticles for theranostic applications: From hydrophilic modification to multimodal imaging and therapy.Materials today. Bio · 2026Review
- Upconverting Nanoparticles Functionalized with Protein-Gold Nanoclusters and Chlorin e6 for Near-Infrared-Activated Photodynamic Therapy.Nanomaterials (Basel, Switzerland) · 2026Article
- Theranostic Verteporfin-Conjugated Upconversion Nanoparticles for Cancer Treatment.Nanomaterials (Basel, Switzerland) · 2025Article
- Sustainable Nanotechnology Strategies for Modulating the Human Gut Microbiota.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of functional nanoprobes for biomedical applications is highly important in the field of modern nanotechnology. Due to strict requirements, such as the ability to be excited using irradiation, which allows deep tissue penetration, nonblinking behavior, and good optical and colloidal stability, the choice of nanoparticles is limited, and their synthesis is challenging. Among all of the functional nanoprobes for biomedical purposes, upconverting nanoparticles, especially those with more complex architectures (e.g., core-shell or core-shell-shell), are the most promising candidates. This study demonstrates advanced synthetic routes for constructing biocompatible nanoprobes with tunable optical properties and colloidal stability. The core-shell-shell architecture of the nanoprobes allows excitation from at least four sources, such as 272 and 394 nm of near-ultraviolet (near-UV) irradiation and 980 and 808 nm near-infrared (NIR) lasers. Furthermore, Gd-matrix-based nanoprobes doped with lanthanide ions (Nd
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.